The estimated Net Worth of Michael Bonner is at least $298 Thousand dollars as of 28 August 2018. Mr. Bonner owns over 400 units of Cumberland Pharmaceuticals stock worth over $24,915 and over the last 9 years he sold CPIX stock worth over $0. In addition, he makes $273,066 as Senior Director Finance and Accounting and Chief Financial Officer at Cumberland Pharmaceuticals.
Sign up
Mr. Bonner CPIX stock SEC Form 4 insiders trading
Michael has made over 8 trades of the Cumberland Pharmaceuticals stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 400 units of CPIX stock worth $2,400 on 28 August 2018.
The largest trade he's ever made was buying 900 units of Cumberland Pharmaceuticals stock on 23 March 2017 worth over $5,778. On average, Michael trades about 304 units every 50 days since 2016. As of 28 August 2018 he still owns at least 18,454 units of Cumberland Pharmaceuticals stock.
You can see the complete history of Mr. Bonner stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Bonner biography
Michael P. Bonner CPA serves as Senior Director Finance and Accounting and Chief Financial Officer of the Company. Mr. Bonner had served as the Company’s Director, Financial and Tax Reporting since January 2013 with expanded responsibilities since October 2015. Mr. Bonner has 20 years of finance and accounting experience, primarily within the health care industry. Prior to joining Cumberland, his most recent position was at Advocat Inc. a then $300 million NASDAQ listed health care provider, as Vice President of Accounting and Financial Reporting. Prior to that, he had similar responsibilities at LifePoint Health, a then NASDAQ listed health care provider. Mr. Bonner started his career in the assurance practice at Ernst & Young. A Certified Public Accountant, Mr. Bonner has a Bachelor of Science in accounting and business administration and his MBA with an emphasis in accounting from Troy University.
What is the salary of Michael Bonner?
As the Senior Director Finance and Accounting and Chief Financial Officer of Cumberland Pharmaceuticals, the total compensation of Michael Bonner at Cumberland Pharmaceuticals is $273,066. There are 8 executives at Cumberland Pharmaceuticals getting paid more, with A. Kazimi having the highest compensation of $1,477,300.
How old is Michael Bonner?
Michael Bonner is 43, he's been the Senior Director Finance and Accounting and Chief Financial Officer of Cumberland Pharmaceuticals since 2016. There are 18 older and 1 younger executives at Cumberland Pharmaceuticals. The oldest executive at Cumberland Pharmaceuticals Inc. is Jonathan Griggs, 85, who is the Independent Director.
What's Michael Bonner's mailing address?
Michael's mailing address filed with the SEC is 2525 WEST END AVENUE, SUITE 950, , NASHVILLE, TN, 37203.
Insiders trading at Cumberland Pharmaceuticals
Over the last 15 years, insiders at Cumberland Pharmaceuticals have traded over $4,393,644 worth of Cumberland Pharmaceuticals stock and bought 265,077 units worth $1,208,228 . The most active insiders traders include Joey A Jacobs, Leo Pavliv, and Thomas R Lawrence. On average, Cumberland Pharmaceuticals executives and independent directors trade stock every 29 days with the average trade being worth of $10,407. The most recent stock trade was executed by Caroline Young on 1 December 2022, trading 379 units of CPIX stock currently worth $849.
What does Cumberland Pharmaceuticals do?
cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.
What does Cumberland Pharmaceuticals's logo look like?
Complete history of Mr. Bonner stock trades at Cumberland Pharmaceuticals
Cumberland Pharmaceuticals executives and stock owners
Cumberland Pharmaceuticals executives and other stock owners filed with the SEC include:
-
A. Kazimi,
Chairman of the Board, Chief Executive Officer -
A. J. Kazimi,
Founder, Chairman, Pres & CEO -
Leo Pavliv,
Executive Vice President - Operations, Chief Development Officer -
Leo B. Pavliv,
Exec. VP of Operations & Chief Devel. Officer -
Martin Cearnal,
Executive Vice President, Chief Commercial Officer, Director -
Martin E. Cearnal,
Exec. VP, Chief Commercial Officer & Director -
James Herman,
Vice President - National Accounts, Chief Compliance Officer -
James Lowrance Herman,
Sr. VP of National Accounts & Chief Compliance Officer -
Michael Bonner,
Senior Director Finance and Accounting and Chief Financial Officer -
Caroline Young,
Independent Director -
Kenneth Krogulski,
Independent Director -
James Jones,
Independent Director -
Joey Jacobs,
Independent Director -
Jonathan Griggs,
Independent Director -
Joseph Galante,
Independent Director -
Gordon Bernard,
Independent Director -
Erin Smith Gull,
Sr. Corp. Relations Associate -
Adam S. Mostafa,
Managing Director -
Cindy B. Patton,
Sr. Director of Field Marketing -
Jean W. Marstiller,
Sr. VP of Admin. Services & Corp. Sec. -
John Michael Hamm,
Director of Fin. & Accounting and CFO -
Thomas R Lawrence,
Director -
Martin S Jr Brown,
-
Chris T. Bitterman,
Vice Pres Sales & Marketing -
Rick Scott Greene,
Chief Financial Officer -
Robert Edwards,
Director -
Jean W Marstiller,
Sr. VP & Corp. Secretary -
Lawrence W Greer,
Director -
David L Lowrance,
Vice President and CFO -
Todd M. Anthony,
Vice Pres Organizational Dev -
John M. Hamm,
VP Chief Financial Officer